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and the total deaths of the no-LVAD
group resulted from a follow-up of 19
years. Hence, it is not surprising that,
in terms of death counts, the initial 30
days in the LVAD group included
a much higher percentage of total
deaths than in the no-LVAD group;
this is simply because 30 days weigh
much ‘‘more’’ in comparison to 6
years than in comparison to 19 years.
Thus, we welcome a re-presentation
of this important finding, in the man-
ner we have mentioned above, no mat-
ter if the new P value will remain, as
we expect, far from the level of statis-
tical significance.
Andrea Messori, PharmD
Sabrina Trippoli, PharmD
Laboratory of Pharmacoeconomics
Careggi Hospital
Firenze, Italy
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NONOPERATIVE
MANAGEMENT OFAN
EXTENSIVE TRACHEAL
INJURY IN AN 860-g PRETERM
NEONATE
To the Editor:
We read with great interest the re-
port of Denlinger and colleagues1 on
nonoperative management of large tra-
cheal injuries in adult patients. Neona-
tal airway complexities are extremely
rare and are usually associated with
congenital tracheal stenosis rather
than iatrogenic complications. Due to
the neonate’s tracheal diameter, in-
juries in neonates most commonly oc-
cur in the subglottic anterior wall or
cricothyroid junction in contrast to
the common posterior wall injury in
adults. Because the management deci-
sions in our patient were extrapolated
from the experience with older pa-
tients, Denlinger and associates’1
article is an excellent segue to share
an extremely rare complication of an
iatrogenic posterior wall tracheal injury
in a premature neonate from orotra-
cheal intubation.
A preterm neonate born spontane-
ously at 25 3/7 weeks of gestation,
weighing 860 g and measuring 33
cm, had been orotracheally intubated
for respiratory failure. The infant had
worsening failure with progressive bi-
lateral pneumothoraces and a pneumo-
mediastinum and was transferred to
our institution. Chest roentgenogram
(Figure 1) showed the distal portion
of a 2.5-mm endotracheal tube below
the diaphragm. Bronchoscopy re-
vealed the entire membranous and
a portion of the cartilaginous trachea
to be disrupted at the carina for nearly
two-thirds the total tracheal circumfer-
ence. The endotracheal tube was posi-
tioned 1 cm above the injury, and
low-pressure ventilation was provided
until the patient was initially extu-
bated 36 hours later before being rein-
tubated several days later. Pleural
drains were placed and broad-spec-
trum antibiotics were continued for
28 days. Repeat bronchoscopy at 9,
12, and 20 days revealed progressive
healing without evidence of stenosis.
There was never evidence of mediasti-
nitis, and the mediastinal emphysema
resolved. Twenty days after initial
presentation, a persistent patent duc-
tus arteriosis contributing to pulmo-
nary overcirculation was ligated.
Surgery was uneventful via a left pos-
terolateral thoracotomy with normal-
appearing mediastinal anatomy. The
neonate was discharged at 118 days
of age.
There are no recommendations for
membranous and/or cartilaginous tra-
cheal injuries in premature neonates.
In older individuals, the literature
supports a conservative nonoperative
management strategy with good results
for membranous injuries with less
optimal outcomes for cartilaginous
injuries.2 However, tracheal surgery
has significant risk and morbidity in ex-
tremely low-birth-weight premature
Letters to the EditorReply to the Editor:
We thank Drs Messori and Trippoli
for their interest. They have critically ex-
amined our statistical methods regarding
early deaths (30 days) following cardiac
transplantation with and without left
ventricular assist devices (LVADs).
From a purely statistical argument, they
are correct: as the LVAD group had
shorter follow-up, 30 days provided
a greater influence in 6 years versus 19
years of follow-up. Upon reanalysis
with the ‘‘traditional presentation,’’ of
the 294 no-LVAD subjects, 23 (8%)
died early. Of the 23 LVAD subjects, 4
(17%) died early. This difference was
indeed, not significant (P¼ .11).
As clinicians, we believe that impor-
tant observations can be learned from
our reported experience.1 Although
we acknowledge this important statisti-
cal correction, we do not believe that
transplantation with an LVAD is theThe Joursame operation as transplantation with-
out an LVAD. Our bedside observa-
tions in caring for these patients have
indicated that when patients trans-
planted from an LVAD develop prob-
lems, these problems often occur
early in the posttransplant period.
This occurrence likely reflects the sur-
gical complexity of explanting the
LVAD. Our primary finding of this re-
port—no difference exists in 1-year
survival after heart transplantation
with or without LVAD—stands.
Joseph C. Cleveland, Jr, MD
Associate Professor of Surgery
Surgical Director, Cardiac
Transplantation and MCS
University of Colorado at Denver
Denver, CO
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